Neuroethics 7 (2):137-158 (2014)

Toni Pustovrh
University of Ljubljana
The article explores some of the issues that have arisen in the discourse on pharmaceutical cognitive enhancement (PCE), that is, the use of stimulant drugs such as methylphenidate, amphetamine and modafinil by healthy individuals of various populations with the aim of improving cognitive performance. Specifically, we explore the presumed sizes of existing PCE user populations and the policy actions that have been proposed regarding the trend of PCE. We begin with an introductory examination of the academic stances and philosophical issues involved in defining PCE. We then focus on an examination of the population sizes of presumed current PCE users that have been listed in the academic literature on PCE, on presuppositions, which have been problematized by some authors as based on anecdotal or misinterpreted survey data. We follow this with an empirical examination of a potential PCE user population in a national context (students at the University of Ljubljana in Slovenia). We then proceed to examine the regulatory options proposed in the academic literature to address PCE, finally comparing them with an empirical overview of the policy recommendations on PCE produced in the multinational context of several national ethics advisory bodies (EABs) in Europe. Our main conclusion is that there is still little debate among the national EABs on what type of public policy responses, if any, are needed to address PCE in European countries, and that the issues they do address are similar to those discussed and proposed in the academic articles on PCE
Keywords Pharmaceutical cognitive enhancement  Drug use  Students  Ethics advisory bodies  Neuroenhancement  Public policy regulation
Categories (categorize this paper)
DOI 10.1007/s12152-013-9192-x
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 56,903
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW]Nick Bostrom - 2009 - Science and Engineering Ethics 15 (3):311-341.

View all 27 references / Add more references

Citations of this work BETA

The Myth of Cognitive Enhancement Drugs.Hazem Zohny - 2015 - Neuroethics 8 (3):257-269.

Add more citations

Similar books and articles

Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW]Nick Bostrom - 2009 - Science and Engineering Ethics 15 (3):311-341.
Neuroenhancing Public Health.David Shaw - 2013 - Journal of Medical Ethics (6):2012-101300.
Cognitive Disability in a Society of Equals.Jonathan Wolff - 2009 - Metaphilosophy 40 (3-4):402-415.
Ethics, Regulation, and Biomedical Research.Matthew Weed - 2004 - Kennedy Institute of Ethics Journal 14 (4):361-368.


Added to PP index

Total views
59 ( #168,794 of 2,409,596 )

Recent downloads (6 months)
4 ( #189,364 of 2,409,596 )

How can I increase my downloads?


My notes